Pasar al contenido principal

REINGENIERIA ESTRUCTURAL DE SISTEMAS MICROBIANOS PARA BIOTERAPIAS, PROTECCION VEGETAL Y BIOTECNOLOGIA APLICADA DE NUEVA GENERACION

PID2024-159901OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para la Investigación y el Desarrollo Experimental
Subprograma Subprograma Estatal de Generación de Conocimiento Científico-Técnico y Desarrollo Experimental
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2024
Plan Estatal 2024-2027 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Targeted enzymatic therapy for coeliac disease

  • Girbal-González, Marina
  • Rodríguez-Banqueri, Arturo
  • Swaid, Hadeel
  • Mendes, Soraia R.
  • Garzón-Flores, Laura
  • Ramírez-Larrota, Juan Sebastián
  • Cueva, Carolina
  • Moreno-Arribas, M. Victoria
  • Regl, Christof
  • Huber, Christian G.
  • Scherf, Katharina A.
  • Rodríguez-Lagunas, María José
  • Franch-Masferrer, Àngels
  • Eckhard, Ulrich
  • Pérez-Cano, Francisco J.
  • Gomis-Rüth, F. Xavier
[Data availability] The coordinates of the experimental celiacase structure determined in this study are retrievable from the Protein Data Bank at www.pdb.org under access code 9QR8. The proteomics datasets are retrievable from Zenodo (https://zenodo.org/records/19456489)., The source data of this paper are collected in the following database record: biostudies:S-SCDT-10_1038-S44321-026-00430-8., Coeliac disease (CD) is an autoimmune enteropathy triggered by proline-rich gluten immunogenic peptides (GIPs), for which no curative therapy exists. We developed celiacase (Clc), a recombinant prolyl endopeptidase engineered from pitcher plant neprosin to enhance expression, stability, and activity. Clc showed maximal activity at gastric pH, synergized with and resisted pepsin, and efficiently cleaved GIPs, including the highly immunogenic 33-mer, outperforming Aspergillus niger prolyl endopeptidase in degrading GIPs from wheat flour and gliadin. At an enzyme-to-gliadin ratio of 1:250, Clc reduced GIP levels by up to 99% in a dynamic human gastrointestinal simulator. Ex vivo, Clc-digested 33-mer fragments failed to elicit cytokine responses in mouse and rat macrophages and duodenal biopsies from CD patients. In vivo, low-dose Clc (1:75-1:380) degraded gliadin and attenuated pathology in gliadin-fed mice, reducing villus atrophy, inflammation, antibody responses, and gluten-induced dysbiosis, while restoring immune-regulatory markers and microbial metabolic pathways. In summary, Clc is a potent, acid-stable glutenase with promise as a therapeutic adjunct or alternative to a gluten-free diet for CD patients., This study was supported in part by funding from public and private bodies, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MCIN/AEI/10.13039/501100011033: PDC2022-133344-I00, PID2022-137827OB-I00, PID2025-171123OB-I00 (FXG-R); RYC2020-029773-I, PID2021-128682OA-I00, PID2024-159901OB-I00, CNS2024-154537 (UE); PRE2020-096731 (JSR-L); PRE2022-000841 (HS); CEX2021-001234-M “María de Maeztu” Unit of Excellence Award (FJP-C). “Vicente Varea 2025” Grant (FJP-C)—Celiac Association of Catalonia. PREDOCS-UB Predoctoral Contract University of Barcelona (2022 call) (MG). Agency for Management of University and Research Grants (AGAUR), Government of Catalonia grant 2021SGR00423 (UE; FXG-R). CONEXIÓN TRIGO Network—Higher Scientific Research Council (CSIC)., With funding from the Spanish government through the "Unit of Excellence Maria de Maeztu" accreditation (CEX2021-001234-M)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The protease code of the bacterial gut microbiota: ecological regulation, barrier disruption, and rewiring host defense and signaling

  • Eckhard, Ulrich
  • Ramírez-Larrota, Juan Sebastián
  • Estevan-Morió, Eva
  • Gomis-Rüth, F. Xavier
The human gastrointestinal tract is home to a dense and diverse microbial ecosystem that functions as a complex superorganism. Yet, the enzymatic machinery responsible for orchestrating this coexistence remains underexplored. Among these enzymes, microbial peptidases (proteases) represent pivotal effectors of the host-microbe interface. Far from acting merely as nonspecific digestive degraders, these proteases serve as highly specific signaling enzymes that can tip the balance between eubiosis and dysbiosis, functioning as critical architects of biofilm structure while also acting as potent virulence factors. This review provides a focused analysis of the microbial proteolytic landscape. We first examine how these enzymes govern community dynamics through the remodeling of biofilm protein matrices and the quenching of peptide-based quorum sensing. At the host-microbe boundary, we detail the hierarchical dismantling of barriers: from mucinases that compromise the protective mucus layer, to the systematic cleavage of adherens junctions by key effectors including enterotoxigenic Bacteroides fragilis toxin, Campylobacter jejuni HtrA, and Porphyromonas gingivalis gingipains. Finally, we explore how proteases transcend physical destruction to manipulate cellular signaling, subverting mucosal immunity via immunoglobulin A cleavage and driving inflammation through the activation of protease-activated receptors., This work was supported by the Spanish Ministry of Science and Innovation (MCIN) and the State Research Agency (AEI) (DOI: 10.13039/501100011033) through grants RYC2020-029773-I, PID2021-128682OA-I00, PID2024-159901OB-I00, and CNS2024-154537 to U.E.; PRE2020-096731 to J.S.R.L.; FPU23/02649 to E.E.M; and PDC2022-133344-I00, PID2025-171123OB-I00, and PID2022-137827OB-I00 to F.X.G.R. These grants were co-funded by the European Union NextGenerationEU/PRTR and the European Regional Development Fund (ERDF) “A way of making Europe”. Additional support was provided by the Government of Catalonia (AGAUR) under grant 2021SGR00423 to U.E. and F.X.G.R., Peer reviewed